Session Details

Speakers, titles, times, and locations of ASGCT presentations

Detailed Program

Friday, May 10 2024
02:15 PM – 02:30 PM ET - Room 307-308

271: Validation of an AAV Gene Therapy Designed to Complement the Loss of TDP-43 Splicing Repression for ALS-FTD

Aswathy Peethambaran Mallika - PhD
Johns Hopkins University School of Medicine

Disclosures:  A. Peethambaran Mallika: None.

Related Abstract

© 2000-2024 All rights reserved. American Society of Gene & Cell Therapy. 

Kentico CMS Development by Reason One | Powered by Kentico

This site uses cookies to offer you a better user experience and to analyze site traffic. By continuing to use this website, you accept our use of cookies.